» Articles » PMID: 8222428

Exostectomy for Symptomatic Bony Prominences in Diabetic Charcot Feet

Overview
Publisher Wolters Kluwer
Specialty Orthopedics
Date 1993 Nov 1
PMID 8222428
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Exostectomy for plantar ulceration is demonstrated to be a satisfactory procedure and one with significantly less morbidity and quicker healing than a more major reconstructive procedure such as arthrodesis. The predominance of Type I (midfoot breakdown) confirms reports on the natural history of the diabetic Charcot tarsus; the midfoot has a tendency to develop symptomatic bony prominences.

Citing Articles

Difficulty in bone union after arthrodesis to treat Charcot arthropathy of the foot and ankle.

Hanada M, Hotta K, Matsuyama Y J Orthop. 2024; 62:13-16.

PMID: 39502675 PMC: 11532133. DOI: 10.1016/j.jor.2024.10.018.


Charcot neuro-osteoarthropathy: a review of key concepts and an evidence-based surgical management algorithm.

Argyropoulos M, Wynell-Mayow W, Johnson O, Faroug R, Johal K, Deol R Front Clin Diabetes Healthc. 2024; 5:1344359.

PMID: 39219847 PMC: 11362032. DOI: 10.3389/fcdhc.2024.1344359.


Surgical management of the diabetic foot: The current evidence.

Roberts R, Davies-Jones G, Brock J, Satheesh V, Robertson G World J Orthop. 2024; 15(5):404-417.

PMID: 38835689 PMC: 11145970. DOI: 10.5312/wjo.v15.i5.404.


Surgical management of Charcot foot - The advancements over the past decade.

Khan O, Kavarthapu M, Edmonds M, Kavarthapu V J Clin Orthop Trauma. 2024; 47:102317.

PMID: 38196500 PMC: 10772398. DOI: 10.1016/j.jcot.2023.102317.


RANKL-RANK-OPG Pathway in Charcot Diabetic Foot: Pathophysiology and Clinical-Therapeutic Implications.

Greco T, Mascio A, Comisi C, Polichetti C, Caravelli S, Mosca M Int J Mol Sci. 2023; 24(3).

PMID: 36769345 PMC: 9917950. DOI: 10.3390/ijms24033014.